IL-17 also increases the concentration of vascular endothelial growth factor (VEGF) to promote tumor angiogenesis and has a unique tumor-promoting effect in human colorectal [78] and gallbladder cancers [79]. Here, VEGFA is linked to gallbladder cancer.